18
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Novel 8-benzoylimidazo[1,2-a] pyridin-5-one mitogen-activated protein kinase inhibitors

Pages 1663-1666 | Published online: 02 Mar 2005

Bibliography

  • LEE JC, KUMAR S, GRISWOLD DE et al.: Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology (2000) 47:185–201.
  • ••Excellent review from a leading group.
  • HERLAAR E, BROWN Z: p38 MAPK signalling cascades in inflammatory disease. MoL Med. Today (1999) 5:439–448.
  • ••Good, well-illustrated review.
  • BOEHM JC, ADAMS JL: New inhibitors of p38 kinase. Expert Opin. Ther. Patents (2000) 10:25–37.
  • ••Reasonably up-to-date review of the patentliterature.
  • DUMAS J, HATOUM-MOKDAD H, SIBLEY R et a/.: 1-Phenyl-5-pyrazoly1 ureas: potent and selective p38 kinase inhibitors. Bioorg. Med. Chem. Lett. (2000) 10:(18)2051–2054.
  • KNOLKER HJ, BOESE R, HITZEMAN R: Imidazole derivatives: part 4. Heterocycles (1989) 29:1551–1558.

Websites

  • http://www.gsk.com/financial/ product_pipeline.htm GlaxoSmithKline product pipeline

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.